Skip to main content
. Author manuscript; available in PMC: 2016 Aug 1.
Published in final edited form as: J Gastrointest Surg. 2015 May 22;19(8):1476–1483. doi: 10.1007/s11605-015-2845-9

Figure 3.

Figure 3

Kaplan-Meier plots of recurrence-free survival according to subgroup: TKI treatment in patients with GIST (a), primary tumor location in patients with LMS (b), and RFA in all patients (c). GIST: gastrointestinal stromal tumor; LMS: leiomyosarcoma; SRC: sarcoma of other or indeterminate origin; TKI: tyrosine kinase inhibitor: RFA: radiofrequency ablation.